Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

Key facts

Sponsor

NICHD Neonatal Research Network

Principal Investigator

Brenda B. Poindexter, MD MS, RN

Indiana University

Intervention

Glutamine(drug)

Enrollment

1433 target

Eligibility

All sexes

Timeline

1999 – 2001

Study locations (15)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Stanford University, Palo Alto, California, United States
• University of California at San Diego, San Diego, California, United States
• Yale University, New Haven, Connecticut, United States
• University of Miami, Miami, Florida, United States
• Emory University, Atlanta, Georgia, United States
• Indiana University, Indianapolis, Indiana, United States
• Wayne State University, Detroit, Michigan, United States
• University of New Mexico, Albuquerque, New Mexico, United States
• RTI International, Durham, North Carolina, United States
• Cincinnati Children's Medical Center, Cincinnati, Ohio, United States
• Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
• Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
• University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
• University of Texas Health Science Center at Houston, Houston, Texas, United States

Collaborators

National Center for Research Resources (NCRR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.